Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06008613 · ClinicalTrials.gov registry record · NA
3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
A NA study of Abdominal Aortic Aneurysm, sponsored by The Cleveland Clinic.
- Active
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT06008613: Active NA study of Abdominal Aortic Aneurysm, sponsored by The Cleveland Clinic.
NCT06008613 is a NA study of Abdominal Aortic Aneurysm that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 3 participants, below the 454-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06008613, a NA study of Abdominal Aortic Aneurysm, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an Early Feasibility Study to evaluate the usability, safety and functionality of 3D holographic guidance, navigation, and control (3D-GNC) as an adjunct to and confirmed by fluoroscopic imaging to be used with Cook Zenith Flex AAA Endovascular Graft.
Primary Outcome
Number of Patients with Correct positioning of the endovascular stent graft using the 3D-GN\&C device confirmed by fluoroscopic imaging
Conditions Studied
Interventions
- DEVICE 3D Holographic Guidance, Navigation, and Control (3D GN&C)
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT06008613 still lists
NCT06008613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 454-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which 3D Holographic Guidance, Navigation, and Control (3D GN&C) is the first listed.
NCT06008613 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06008613 about?
NCT06008613 is a clinical study titled "3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair". This is an Early Feasibility Study to evaluate the usability, safety and functionality of 3D holographic guidance, navigation, and control (3D-GNC) as an adjunct to and confirmed by fluoroscopic imaging to be used with Cook Zenith Flex AAA Endovascular Graft.
What is the current status of trial NCT06008613?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2023-10-18. Estimated completion is 2025-12-31.
What conditions does trial NCT06008613 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.
What interventions are being tested in trial NCT06008613?
The interventions under investigation include: 3D Holographic Guidance, Navigation, and Control (3D GN&C) (DEVICE).
Who is sponsoring clinical trial NCT06008613?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06008613 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06008613's enrollment target sits among peer trials
3 16th of 16 higher than 1 of 16 other Abdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
Post-Approval Study of the TREO Abdominal Stent-Graft System
ACTIVE NOT RECRUITING · NA
-
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
COMPLETED · NA
-
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI